FDX1 and acute myeloid leukemia: There is a negative relationship between FDX1 expression and ICP genes in ACC, DLBC, LAML (acute myeloid leukemia), LIHC, THCA and THYM, which suggests that high FDX1 expression may predict unsatisfactory immunotherapy results when targeting these genes.